Corrado Advisors’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-180
| Closed | -$14.9K | – | 387 |
|
|
2022
Q4 | $14.9K | Buy |
+180
| New | +$14.9K | 0.01% | 208 |
|
|
2020
Q2 | – | Sell |
-7,140
| Closed | -$552K | – | 84 |
|
|
2020
Q1 | $552K | Buy |
7,140
+1,852
| +35% | +$143K | 0.52% | 38 |
|
|
2019
Q4 | $503K | Buy |
5,288
+185
| +4% | +$17.6K | 0.45% | 40 |
|
|
2019
Q3 | $389K | Buy |
5,103
+235
| +5% | +$17.9K | 0.35% | 50 |
|
|
2019
Q2 | $427K | Buy |
4,868
+297
| +6% | +$26.1K | 0.38% | 46 |
|
|
2019
Q1 | $414K | Buy |
4,571
+55
| +1% | +$4.98K | 0.38% | 46 |
|
|
2018
Q4 | $324K | Buy |
4,516
+20
| +0.4% | +$1.44K | 0.32% | 55 |
|
|
2018
Q3 | $431K | Buy |
4,496
+308
| +7% | +$29.5K | 0.28% | 58 |
|
|
2018
Q2 | $398K | Buy |
4,188
+365
| +10% | +$34.7K | 0.24% | 68 |
|
|
2018
Q1 | $335K | Buy |
+3,823
| New | +$335K | 0.2% | 78 |
|